Vascularized Composite Allograft Rejection Is Delayed by Intrajejunal Treatment with Donor Splenocytes without Concomitant Immunosuppressants

Vascularized Composite Allograft Rejection Is Delayed by Intrajejunal Treatment with Donor Splenocytes without Concomitant Immunosuppressants

Background. Mucosal or oral tolerance, an established method for inducing low-risk antigen-specific hyporesponsiveness, has not been investigated in vascularized composite allograft (VCA) research. We studied its effects on recipient immune responses and VCA rejection. Methods. Lewis rats (n = 12;...

Full description

Bibliographic Details
Main Authors: Wallace, Christopher Glenn, Yen, Chia-Hung, Yang, Hsiang-Chen, Lin, Chun-Yen, Wu, Ren-Chin, Huang, Wei-Chao, Lin, Jeng-Yee, Wei, Fu-Chan
Format: Online
Language:English
Published: Hindawi Publishing Corporation 2012
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3514848/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3514848/

Similar Items